|
1) Valera EM, Faraone SV, Murray KE, et al. Meta-analysis of structural imaging findings in attention-deficit/hyperactivity disorder. Biol Psychiatry. 2007; 61: 1361-9
|
|
|
|
2) Seidman LJ, Valera EM, Markris N, et al. Dorsolateral prefrontal and anterior cingulate cortex volumetric abnormalities in adults with attention-deficit/ Hyperactivity disorder identified by magnetic resonance imaging. Biol Psychiatry. 2006; 60: 1071-8
|
|
|
|
|
|
3) Dickstein SG, Bannon K, Castellanos FX, et al. The neural correlates of attention deficit hyperactivity disorder. an ALE meta-analysis. J Child Psychol Psychiatry. 2006; 47: 1051-62
|
|
|
|
|
|
4) Schultz KP, Newcorn JH, Fan J, et al. Brain activation gradients in ventrolateral prefrontal cortex related to persistence of ADHD in adolescent boys. J Am Acad Child Adolesc Psychiatry. 2005; 44: 47-55
|
|
|
|
|
|
5) Tamm L, Menon V, Ringel J, et al. Event-related fMRI evidence of frontotemporal involvement in aberrant response inhibition and task switching in attention-deficit/ hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2004; 43: 1430-7
|
|
|
|
|
|
6) Fallgatter AJ, Ehlis AC, Seifert J, et al. Altered response control and anterior cingulate function in attention-deficit/hyperactivity disorder boys. Clin Neurophysiol. 2004; 115: 973-9
|
|
|
|
|
|
7) Ashtari M, Kumra S, Bhaskar SL, et al. Attention-deficit/hyperactivity disorder: a preliminary diffusion tensor imaging study. Biol Psychiatry. 2005; 57: 448-57
|
|
|
|
|
|
8) Casey BJ, Epstein JN, Buhle J, et al. Frontostriatal connectivity and its role in cognitive control in parent-child dyads with ADHD. Am J Psychiatry. 2007; 164: 1729-36
|
|
|
|
|
|
9) Schweitzer JB, Lee DO, Hanford RB, et al. A positron emission tomography study of methylphenidate in adults with ADHD: Alterations in resting blood flow and predicting treatment response. Neuropsychopharmacology. 2003; 28: 967-74
|
|
|
|
|
|
10) Shafritz KM, Marchione KE, Gore JC, et al. The effects of methylphenidate on neural systems of attention in attention deficit hyperactivity disorder. Am J Psychiatry. 2004; 161: 1990-6
|
|
|
|
|
|
11) Lee J, Kim B, Kang E, et al. Regional cerebral blood flow in children with attention deficit hyperactivity disorder: Comparison before and after methylphenidate treatment. Hum Brain Mapp. 2005; 24: 157-65
|
|
|
|
|
|
12) Scheres A, Milham MP, Kunston B, et al. Ventral striatal hyporesponsiveness during reward anticipation in attention-deficit/hyperactivity disorder. Biol Psychiatry. 2007; 61: 720-4
|
|
|
|
|
|
13) Volkow ND, Wang GJ, Fowler JS, et al. Evidence that methylphenidate enhances the saliency of a mathematical task by increasing dopamine in the human brain. Am J Psychiatry. 2004; 161: 1173-80
|
|
|
|
|
|
14) Forssberg H, Fernell E, Waters S, et al. Altered pattern of brain dopamine synthesis in male adolescents with attention deficit hyperactivity disorder. Behav Brain Funct. 2006; 2: 40
|
|
|
|
|
|
15) Volkow ND, Wang GJ, Newcorn J, et al. Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 2007; 64: 932-40
|
|
|
|
|
|
16) Braun JM, Kahn RS, Froehlich T, et al. Exposures to environmental toxicants and attention deficit hyperactivity disorder in U. S. children. Environ Health Perspect. 2006; 114: 1904-9
|
|
|
|
|
|
17) Neuman RJ, Lobos E, Reich W, et al. Prenatal smoking exposure and dopaminergic genotypes interact to cause a severe ADHD subtype. Biol Psychiatry. 2007; 61: 1320-8
|
|
|
|
|
|
18) Ito N, Iida J, Iwasaka H, et al. Study of Event-related potentials in Attention-deficit/ Hyperactivity disorder. Jap J Child Adolesc Psychiatry. 2003; 44(Supplement): 101-11
|
|
|
|
|
|
19) Negoro H, Iida J, Iwasaka H, et al. Can Event-Related Potentials(ERPs) be useful for differential diagnosis of Attention-deficit/Hyperactivity Disorder (ADHD)？ Jap J Child Adolesc Psychiatry. 2006; 47(Supplement): 15-25
|
|
|
|
|
|
20) 澤田将幸, 飯田順三, 根來秀樹, 他. 注意欠陥/多動性障害(ADHD)の衝動性とMismatch negativity (MMN). 精神科治療学. 2005; 21: 987-91
|
|
|
|
|
21) Biederman J, Faraone SV. Attention-deficit hyperactivity disorder. Lancet. 2005; 366: 237-48
|
|
|
|
|
|
22) Monila BS, Flory K, Hinshaw SP, et al. Delinquent behavior and emerging substance use in the MTA at 36 months: prevalence, course, and treatment effects. J Am Acad Child Adolesc Psychiatry. 2007; 46: 1028-40
|
|
|
|
|
|
23) Wilens T, McBurnett K, Stein M, et al. ADHD treatment with once-daily OROS methylphenidate: final results from a long-term open-label study. J Am Acad Child Adolesc Psychiatry. 2005; 44: 1015-23
|
|
|
|
|